Biotech China 2014

Proteomics: Amgen

Total Score People Score Events Score
22 17 11
Date Event Presentation Speakers
March 19, 2014 3rd Neurological Biomarkers Executive Panel: Companion Diagnostics & Partnering Strategies Scott D Patterson
May 19, 2010 Protein Aggregation in Biopharmaceutical Products Analysis of Subvisible Particles in Protein Therapeutics: Methods and Applications Shawn Cao
May 17, 2010 Difficult to Express Proteins Evaluating Host Cell Differences for Difficult to Generate Proteins Jennitte Stevens
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Ligands of Orphan GPCRs Identified from Inducible Expression of the Receptors and Cell-based Reporter Screen Paul Lee
January 26, 2009 Pre-Conference Short Course* Jean W Lee
January 26, 2009 Biomarker Assay Development Quantification of “Total” and/or “Free” Target Protein Biomarker: Approaches and Applications Jean W Lee
January 26, 2009 Translational Cancer Medicine Pre-Conference Short Course* : Fit-for-Purpose Biomarker Assay Development and Validation Jean W Lee
VECTIBIX : The KRAS Signaling Pathway Biomarker in Oncology: From Prognostic to Predictive Scott D Patterson
October 20, 2008 Protein Expression Europe Epitope Mapping with Saturation Mutagenesis: A Case-Study of Single-Chain, Conformation-Sensitive Antibodies to the Erythropoietin Receptor Christopher Mehlin
September 29, 2008 Metabolic Biomarkers Pre-Conference Tutorial* (*Separate Registration Required) Jean W Lee
September 30, 2007 BioProcess International Conference & Exhibition Scaling Up from Bench through Commercialization , Best Practices for Strategic Scale Up Decisions (07:00 - 12:15) Robert J. Todd
Best Practices for Strategic Scale Up Decisions: Connecting the Dots between Process Platforms and Facility Design Robert J. Todd
Enhancing Operational Excellence and Process Efficiencies : Chairperson's Remarks Duncan Low
Production & Economics of Biopharmaceuticals : Enhancing Operational Excellence and Process Efficiencies (13:45 - 15:30) Duncan Low
Scaling Up from Bench through Commercialization ; Scale Down Models, Process Characterization and Validation (08:00 - 12:00) Roger A. Hart, Steven K. Rausch
Scale Down Models, Process Characterization and Validation : Chairperson's Remarks Roger A. Hart
Scale Down Models, Process Characterization and Validation : A Novel Statistical Approach to Setting Process Validation Acceptance Criteria Steven K. Rausch
Overcoming the Challenges of the Ton Scale Process : Chairperson's Remarks Brian R. Hubbard
Recovery & Purification ; Overcoming the Challenges of the Ton Scale Process (13:45 - 16:00) Brian R. Hubbard
Regulatory Guidance, Validation & Viral Clearance (16:00 - 18:00) R. Scott Rosenthal
Regulatory Guidance, Validation & Viral Clearance : Evaluation of Process and Product Impact of UVC Treatment on a mAb Process R. Scott Rosenthal
Late Stage Process Development - Improving Yield and Quality : Industry Perspective on Reducing Lot-to-Lot Hydrolysate Variability Thomas Seewoester
Late Stage Process Development - Improving Yield and Quality (08:15 - 12:00) Thomas Seewoester, Kenneth Green
Late Stage Process Development - Improving Yield and Quality : The Application of Root Cause Analysis and Investigational Tools to Identify and Resolve Cell Culture Issues Observed at Commercial Scale during Technology Transfer Kenneth Green
Improving Downstream Economies and Efficiencies with Disposables, Platforms and Quality by Design : Impact and Benefits of Applying Quality by Design(QbD) in Cell Line Development to Downstream Process Development Pranhitha Reddy
Improving Downstream Economies and Efficiencies with Disposables, Platforms and Quality by Design (08:15 - 10:45) Pranhitha Reddy
Commercial Process Readiness, Troubleshooting and Improvements (13:45 - 17:00) Carin Gray
Commercial Process Readiness, Troubleshooting and Improvements : Characterization of the Operating Parameters for the WAVE Bioreactor Expansion Stages of a Commercial Scale Cell Culture Production Process Carin Gray
Novel Process Development Strategies (13:45 - 17:00) Yuefeng Lu
Novel Process Development Strategies : Exploring "Hot Spots" In Recombinant Monoclonal Antibody Molecules Yuefeng Lu
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Pre-Conference Workshops; Biomarker Assay Development and Validation: Part I Tutorial FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION (08:00-12:00) Jean W Lee
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.